Cargando…

The orphan nuclear receptor EAR-2 (NR2F6) inhibits hematopoietic cell differentiation and induces myeloid dysplasia in vivo

BACKGROUND: In patients with myelodysplastic syndrome (MDS), bone marrow cells have an increased predisposition to apoptosis, yet MDS cells outcompete normal bone marrow (BM)-- suggesting that factors regulating growth potential may be important in MDS. We previously identified v-Erb A related-2 (EA...

Descripción completa

Detalles Bibliográficos
Autores principales: Ichim, Christine V., Dervovic, Dzana D., Chan, Lap Shu Alan, Robertson, Claire J., Chesney, Alden, Reis, Marciano D., Wells, Richard A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286615/
https://www.ncbi.nlm.nih.gov/pubmed/30555701
http://dx.doi.org/10.1186/s40364-018-0149-4
_version_ 1783379494818545664
author Ichim, Christine V.
Dervovic, Dzana D.
Chan, Lap Shu Alan
Robertson, Claire J.
Chesney, Alden
Reis, Marciano D.
Wells, Richard A.
author_facet Ichim, Christine V.
Dervovic, Dzana D.
Chan, Lap Shu Alan
Robertson, Claire J.
Chesney, Alden
Reis, Marciano D.
Wells, Richard A.
author_sort Ichim, Christine V.
collection PubMed
description BACKGROUND: In patients with myelodysplastic syndrome (MDS), bone marrow cells have an increased predisposition to apoptosis, yet MDS cells outcompete normal bone marrow (BM)-- suggesting that factors regulating growth potential may be important in MDS. We previously identified v-Erb A related-2 (EAR-2, NR2F6) as a gene involved in control of growth ability. METHODS: Bone marrow obtained from C57BL/6 mice was transfected with a retrovirus containing EAR-2-IRES-GFP. Ex vivo transduced cells were flow sorted. In some experiments cells were cultured in vitro, in other experiments cells were injected into lethally irradiated recipients, along with non-transduced bone marrow cells. Short-hairpin RNA silencing EAR-2 was also introduced into bone marrow cells cultured ex vivo. RESULTS: Here, we show that EAR-2 inhibits maturation of normal BM in vitro and in vivo and that EAR-2 transplant chimeras demonstrate key features of MDS. Competitive repopulation of lethally irradiated murine hosts with EAR-2-transduced BM cells resulted in increased engraftment and increased colony formation in serial replating experiments. Recipients of EAR-2-transduced grafts had hypercellular BM, erythroid dysplasia, abnormal localization of immature precursors and increased blasts; secondary transplantation resulted in acute leukemia. Animals were cytopenic, having reduced numbers of erythrocytes, monocytes and granulocytes. Suspension culture confirmed that EAR-2 inhibits granulocytic and monocytic differentiation, while knockdown induced granulocytic differentiation. We observed a reduction in the number of BFU-E and CFU-GM colonies and the size of erythroid and myeloid colonies. Serial replating of transduced hematopoietic colonies revealed extended replating potential in EAR-2-overexpressing BM, while knockdown reduced re-plating ability. EAR-2 functions by recruitment of histone deacetylases, and inhibition of differentiation in 32D cells is dependent on the DNA binding domain. CONCLUSIONS: This data suggest that NR2F6 inhibits maturation of normal BM in vitro and in vivo and that the NR2F6 transplant chimera system demonstrates key features of MDS, and could provide a mouse model for MDS. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40364-018-0149-4) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6286615
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-62866152018-12-14 The orphan nuclear receptor EAR-2 (NR2F6) inhibits hematopoietic cell differentiation and induces myeloid dysplasia in vivo Ichim, Christine V. Dervovic, Dzana D. Chan, Lap Shu Alan Robertson, Claire J. Chesney, Alden Reis, Marciano D. Wells, Richard A. Biomark Res Research BACKGROUND: In patients with myelodysplastic syndrome (MDS), bone marrow cells have an increased predisposition to apoptosis, yet MDS cells outcompete normal bone marrow (BM)-- suggesting that factors regulating growth potential may be important in MDS. We previously identified v-Erb A related-2 (EAR-2, NR2F6) as a gene involved in control of growth ability. METHODS: Bone marrow obtained from C57BL/6 mice was transfected with a retrovirus containing EAR-2-IRES-GFP. Ex vivo transduced cells were flow sorted. In some experiments cells were cultured in vitro, in other experiments cells were injected into lethally irradiated recipients, along with non-transduced bone marrow cells. Short-hairpin RNA silencing EAR-2 was also introduced into bone marrow cells cultured ex vivo. RESULTS: Here, we show that EAR-2 inhibits maturation of normal BM in vitro and in vivo and that EAR-2 transplant chimeras demonstrate key features of MDS. Competitive repopulation of lethally irradiated murine hosts with EAR-2-transduced BM cells resulted in increased engraftment and increased colony formation in serial replating experiments. Recipients of EAR-2-transduced grafts had hypercellular BM, erythroid dysplasia, abnormal localization of immature precursors and increased blasts; secondary transplantation resulted in acute leukemia. Animals were cytopenic, having reduced numbers of erythrocytes, monocytes and granulocytes. Suspension culture confirmed that EAR-2 inhibits granulocytic and monocytic differentiation, while knockdown induced granulocytic differentiation. We observed a reduction in the number of BFU-E and CFU-GM colonies and the size of erythroid and myeloid colonies. Serial replating of transduced hematopoietic colonies revealed extended replating potential in EAR-2-overexpressing BM, while knockdown reduced re-plating ability. EAR-2 functions by recruitment of histone deacetylases, and inhibition of differentiation in 32D cells is dependent on the DNA binding domain. CONCLUSIONS: This data suggest that NR2F6 inhibits maturation of normal BM in vitro and in vivo and that the NR2F6 transplant chimera system demonstrates key features of MDS, and could provide a mouse model for MDS. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40364-018-0149-4) contains supplementary material, which is available to authorized users. BioMed Central 2018-12-07 /pmc/articles/PMC6286615/ /pubmed/30555701 http://dx.doi.org/10.1186/s40364-018-0149-4 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Ichim, Christine V.
Dervovic, Dzana D.
Chan, Lap Shu Alan
Robertson, Claire J.
Chesney, Alden
Reis, Marciano D.
Wells, Richard A.
The orphan nuclear receptor EAR-2 (NR2F6) inhibits hematopoietic cell differentiation and induces myeloid dysplasia in vivo
title The orphan nuclear receptor EAR-2 (NR2F6) inhibits hematopoietic cell differentiation and induces myeloid dysplasia in vivo
title_full The orphan nuclear receptor EAR-2 (NR2F6) inhibits hematopoietic cell differentiation and induces myeloid dysplasia in vivo
title_fullStr The orphan nuclear receptor EAR-2 (NR2F6) inhibits hematopoietic cell differentiation and induces myeloid dysplasia in vivo
title_full_unstemmed The orphan nuclear receptor EAR-2 (NR2F6) inhibits hematopoietic cell differentiation and induces myeloid dysplasia in vivo
title_short The orphan nuclear receptor EAR-2 (NR2F6) inhibits hematopoietic cell differentiation and induces myeloid dysplasia in vivo
title_sort orphan nuclear receptor ear-2 (nr2f6) inhibits hematopoietic cell differentiation and induces myeloid dysplasia in vivo
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286615/
https://www.ncbi.nlm.nih.gov/pubmed/30555701
http://dx.doi.org/10.1186/s40364-018-0149-4
work_keys_str_mv AT ichimchristinev theorphannuclearreceptorear2nr2f6inhibitshematopoieticcelldifferentiationandinducesmyeloiddysplasiainvivo
AT dervovicdzanad theorphannuclearreceptorear2nr2f6inhibitshematopoieticcelldifferentiationandinducesmyeloiddysplasiainvivo
AT chanlapshualan theorphannuclearreceptorear2nr2f6inhibitshematopoieticcelldifferentiationandinducesmyeloiddysplasiainvivo
AT robertsonclairej theorphannuclearreceptorear2nr2f6inhibitshematopoieticcelldifferentiationandinducesmyeloiddysplasiainvivo
AT chesneyalden theorphannuclearreceptorear2nr2f6inhibitshematopoieticcelldifferentiationandinducesmyeloiddysplasiainvivo
AT reismarcianod theorphannuclearreceptorear2nr2f6inhibitshematopoieticcelldifferentiationandinducesmyeloiddysplasiainvivo
AT wellsricharda theorphannuclearreceptorear2nr2f6inhibitshematopoieticcelldifferentiationandinducesmyeloiddysplasiainvivo
AT ichimchristinev orphannuclearreceptorear2nr2f6inhibitshematopoieticcelldifferentiationandinducesmyeloiddysplasiainvivo
AT dervovicdzanad orphannuclearreceptorear2nr2f6inhibitshematopoieticcelldifferentiationandinducesmyeloiddysplasiainvivo
AT chanlapshualan orphannuclearreceptorear2nr2f6inhibitshematopoieticcelldifferentiationandinducesmyeloiddysplasiainvivo
AT robertsonclairej orphannuclearreceptorear2nr2f6inhibitshematopoieticcelldifferentiationandinducesmyeloiddysplasiainvivo
AT chesneyalden orphannuclearreceptorear2nr2f6inhibitshematopoieticcelldifferentiationandinducesmyeloiddysplasiainvivo
AT reismarcianod orphannuclearreceptorear2nr2f6inhibitshematopoieticcelldifferentiationandinducesmyeloiddysplasiainvivo
AT wellsricharda orphannuclearreceptorear2nr2f6inhibitshematopoieticcelldifferentiationandinducesmyeloiddysplasiainvivo